Invention Grant
- Patent Title: Peptides and anti-cancer compositions including thereof
-
Application No.: US18070125Application Date: 2022-11-28
-
Publication No.: US12024546B2Publication Date: 2024-07-02
- Inventor: Jeong Seok Nam , So Yeon Park , Tae Young Jang
- Applicant: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Gwangju
- Assignee: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: KR Gwangju
- Agency: The PL Law Group, PLLC
- Priority: KR 20220055955 2022.05.06 KR 20220082526 2022.07.05
- Main IPC: C07K14/00
- IPC: C07K14/00 ; A61P35/00 ; C07K14/78
Abstract:
A peptide according to an embodiment may be used as an anti-cancer agent. The peptide has a binding activity to fibronectin and competitively binds to fibronectin with dysadherin. Therefore, the peptide may be used to prevent binding between dysadherin in a cell membrane of cancer cells and fibronectin in ECM, and may be used as an anti-cancer agent to weaken survival, migration or invasion of cancer cells.
Public/Granted literature
- US20230357362A1 NOVEL PEPTIDES AND ANTI-CANCER COMPOSITIONS INCLUDING THEREOF Public/Granted day:2023-11-09
Information query
